omniture
logo
Search
纽福斯（上海）生物科技有限公司
Media Room

Latest News

rss

Neurophth Closes RMB 400 Million Series B Financing

Proceeds to support – * continued development of robust portfolio of AAV-delivered therapeutics ...

2021-02-09 21:44 1995
Neurophth Closes RMB 400 Million Series B Financing

Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer

WUHAN, China and NEWARK, Del., Jan. 27, 2021 /PRNewswire/ -- Wuhan Neurophth Biotechnology Ltd., a ...

2021-01-27 21:00 1496
Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer

Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy

WUHAN, China and NEWARK, DE., Jan. 19, 2021 /PRNewswire/ -- Neurophth Therapeutics, Inc., a subsidi...

2021-01-19 14:05 1471

Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA

NEWARK, Del., Sept. 24, 2020 /PRNewswire/ -- Neurophth Therapeutics, Inc., (hereinafter referred to...

2020-09-25 10:37 2323
Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA

Neurophth Therapeutics Announces Presentations at ASGCT and ARVO Annual Meetings

BOSTON and WUHAN, China, May 11, 2020 /PRNewswire/ -- Neurophth Therapeutics, Inc., a clinical-stag...

2020-05-11 20:00 1571
12